rs397515538
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001024630.4(RUNX2):c.90delC(p.Ser31fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000125 in 1,605,386 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 30)
Exomes 𝑓: 6.9e-7 ( 0 hom. )
Consequence
RUNX2
NM_001024630.4 frameshift
NM_001024630.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.871
Genes affected
RUNX2 (HGNC:10472): (RUNX family transcription factor 2) This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 44 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-45422617-GC-G is Pathogenic according to our data. Variant chr6-45422617-GC-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 929063.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RUNX2 | NM_001024630.4 | c.90delC | p.Ser31fs | frameshift_variant | 3/9 | ENST00000647337.2 | NP_001019801.3 | |
RUNX2 | NM_001369405.1 | c.48delC | p.Ser17fs | frameshift_variant | 1/7 | NP_001356334.1 | ||
RUNX2 | NM_001015051.4 | c.90delC | p.Ser31fs | frameshift_variant | 3/8 | NP_001015051.3 | ||
RUNX2 | NM_001278478.2 | c.48delC | p.Ser17fs | frameshift_variant | 1/6 | NP_001265407.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RUNX2 | ENST00000647337.2 | c.90delC | p.Ser31fs | frameshift_variant | 3/9 | NM_001024630.4 | ENSP00000495497.1 |
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151218Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
1
AN:
151218
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 6.88e-7 AC: 1AN: 1454168Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 723226
GnomAD4 exome
AF:
AC:
1
AN:
1454168
Hom.:
Cov.:
34
AF XY:
AC XY:
0
AN XY:
723226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151218Hom.: 0 Cov.: 30 AF XY: 0.0000136 AC XY: 1AN XY: 73760
GnomAD4 genome
AF:
AC:
1
AN:
151218
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
73760
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cleidocranial dysostosis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 11, 2019 | Variant summary: RUNX2 c.90delC (p.Ser31ProfsX9) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay (NMD), which are commonly known mechanisms for disease. However, downstream from the variant, there is a second ATG codon in an appropriate context for translational initiation, and at least one in vitro study has described that a construct containing only the second ATG codon (i.e. Met39) was nearly as active as the WT construct containing both; on the other hand, the same study demonstrated that deletion of the first 38 amino acid residues led to a partial decrease in transactivation activity (PMID: 9632804). The variant was observed in 1/31166 control chromosomes (gnomAD database, genome dataset). To our knowledge, no occurrence of c.90delC in individuals affected with Cleidocranial Dysplasia (CCD) and no experimental evidence demonstrating its impact on protein function have been reported. However, different variant, affecting the same nucleotide position, and resulting in a similar protein level change (i.e. a frameshift), RUNX2 c.90dupC (p.Ser31Leufs), has been described in the literature in a proband with mild CCD, and with significant intrafamilial variability in expressivity, leading the authors to interpret this variant as a hypomorphic allele, which could be possibly explained by the utilization of the downstream ATG codon for translational initiation (PMID: 10545612). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant of interest could possibly represent a hypomorphic variant associated with milder phenotype, or potentially even a typical truncating variant associated with a more severe phenotype (based on NMD), therefore it was classified as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at